A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 12, 2008 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: Year Number 12…And Still Much Work to Do Allen Loyd V Jr	Jan/Feb 2008 Pg. 4
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Dib Jean G, Abdulmohsin Saud	Jan/Feb 2008 Pg. 8-14
Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients Williams LaVonn A	Jan/Feb 2008 Pg. 16-27
Hospice and Compounding Pharmacy: Once Inseperable Williams LaVonn A	Jan/Feb 2008 Pg. 28-37
Disposing of Expired Drugs and Chemicals: New Options for Compounders Vail Jane	Jan/Feb 2008 Pg. 38-47 View Sample
Websites: Keeping Current in 2008 Storey Patricia L	Jan/Feb 2008 Pg. 48-49
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method Kupiec Thomas C, Skinner Rodney, Lanier Lance	Jan/Feb 2008 Pg. 50-53
Calculations: Compounding for Cancer Patients Stockton Shelly J	Jan/Feb 2008 Pg. 62
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Allen Loyd V Jr	Jan/Feb 2008 Pg. 63
Cyclosporine Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 64
Diclofenac Sodium 1% Soft-Patch Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 65
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 66
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Allen Loyd V Jr, Okeke Claudia C	Jan/Feb 2008 Pg. 54-60
Diltiazem 5% in Lipoderm, Veterinary Allen Loyd V Jr	Jan/Feb 2008 Pg. 67
Emetine Hydrochloride 30-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2008 Pg. 68
Flosulide 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2008 Pg. 69
Pentoxifylline 20-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2008 Pg. 70
Piroxicam 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 71
Piroxicam 1% Soft-Patch Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 72
Trimethoprim 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2008 Pg. 73
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Huffman DC, Holmes Erin R	Jan/Feb 2008 Pg. 74-82
Room Temperature Stability of Injectable Succinylcholine Dichloride Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice	Jan/Feb 2008 Pg. 83-85
2007 Reviewers	Jan/Feb 2008 Pg. 86
PostScription: Consumer Options for Disposal of Unused Medications Vail Jane	Jan/Feb 2008 Pg. 87
PreScription: Compounding Around the World Allen Loyd V Jr	Mar/Apr 2008 Pg. 92
Current Compounding Practices in Europe Carvalho Maria, Tuleu Catherine, Taylor Kevin MG	Mar/Apr 2008 Pg. 94-99
Compounding Around the World Vail Jane	Mar/Apr 2008 Pg. 102-115
Establishing a Quality-Assurance Program for Hospital Compounding McElhiney Linda F	Mar/Apr 2008 Pg. 116-120
Hormone Therapy: It's Time for a Second Opinion Collins Joseph J, Ahlgrimm Maria	Mar/Apr 2008 Pg. 122-127
Newsletters: An Essential Marketing Tool Storey Patricia L	Mar/Apr 2008 Pg. 128-129
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Odegard Russell D	Mar/Apr 2008 Pg. 130-135
Calculations Stockton Shelly J	Mar/Apr 2008 Pg. 145
Acyclovir 5% Topical Ointment Allen Loyd V Jr	Mar/Apr 2008 Pg. 146
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A	Mar/Apr 2008 Pg. 156-160
Chemical Stability of Tramadol Hydrochloride Injection Gupta Vishnu D	Mar/Apr 2008 Pg. 161-162
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting de Oliveira Ferreira Anderson, Holandino Carla	Mar/Apr 2008 Pg. 163-169
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Murry Tom	Mar/Apr 2008 Pg. 174-175
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C	Mar/Apr 2008 Pg. 136-144
Alum 6.5% Topical Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 147
Aminacrine Hydrochloride 0.1% Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 148
Butesin Picrate 1% ointment Allen Loyd V Jr	Mar/Apr 2008 Pg. 149
Carbamazepine Topical Preparations Allen Loyd V Jr	Mar/Apr 2008 Pg. 150
Chlorhexidine Gel Allen Loyd V Jr	Mar/Apr 2008 Pg. 151
EDTA 1% Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 152
Erythromycin 1% and Neomycin Sulfate Ointment Allen Loyd V Jr	Mar/Apr 2008 Pg. 153
Heparin Gel-Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 154
Hydrogen Peroxide 8% Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 155
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A	Mar/Apr 2008 Pg. 170-173
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Allen Loyd V Jr, Okeke Claudia C	May/Jun 2008 Pg. 252-257
Calculations Stockton Shelly J	May/Jun 2008 Pg. 258
Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription Allen Loyd V Jr	May/Jun 2008 Pg. 259
African Scalp Lotion Allen Loyd V Jr	May/Jun 2008 Pg. 260
Benzyl Benzoate Lotion Allen Loyd V Jr	May/Jun 2008 Pg. 261
Calcium Gluconate 2.5% Topical Gel Allen Loyd V Jr	May/Jun 2008 Pg. 262
Lubricating Gel Allen Loyd V Jr	May/Jun 2008 Pg. 263
Meloxicam 0.3% Topical Gel Allen Loyd V Jr	May/Jun 2008 Pg. 264
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm Allen Loyd V Jr	May/Jun 2008 Pg. 265
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel Allen Loyd V Jr	May/Jun 2008 Pg. 266
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Allen Loyd V Jr	May/Jun 2008 Pg. 267
Tolnaftate 1% Antifungal Microemulsion Allen Loyd V Jr	May/Jun 2008 Pg. 268
Valsartan 4-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2008 Pg. 269
Chemical Stability of Naltrexone Hydrochloride Injection Gupta Vishnu D	May/Jun 2008 Pg. 274-275
PostScription: A Contemporary Perspective on Compounding Education Maine Lucinda L	May/Jun 2008 Pg. 279
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Kastango Eric S	May/Jun 2008 Pg. 216-229
Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations Fyke Jeremy P, Hoffman Mary F	May/Jun 2008 Pg. 230-233
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 3: Developing a Program of Quality Assurance and Continuous Quality Improvement Cabaleiro Joe	May/Jun 2008 Pg. 234-236
PreScription: Pain! Allen Loyd V Jr	May/Jun 2008 Pg. 180
Topical Treatment of Neuropathic Pain Vadaurri Vince	May/Jun 2008 Pg. 182-190
Compounded Local Anesthetics to Minimize Pain from Medical Procedures McElhiney Linda F	May/Jun 2008 Pg. 192-197
Dilution and Compounding of Ziconotide for Intrathecal Administration Buchta Tony, Fakata Keri, Stuart William	May/Jun 2008 Pg. 200-207
Pharmacy Compounding at the University of Connecticut: Secundum Artem et Scientia Scagliarini Meghan, Bogner Robin H	May/Jun 2008 Pg. 208-212
Developing and Implementing a Clinical Pharmacy Rotation in a Community Compounding Pharmacy Walkup Kenny R	May/Jun 2008 Pg. 213-215
Litigating the Legality of Compounding: The Medical Center Pharmacy Case Gibbs Jeffrey N	May/Jun 2008 Pg. 238-241
Developing a Niche Marketing Strategy Storey Patricia L	May/Jun 2008 Pg. 242-243
Web 2.0 and Health 2.0: Are You In? Felkey Bill G	May/Jun 2008 Pg. 244-246
A Process Verification Model for Quality Assurance in a Compounding Pharmacy Zolner William J	May/Jun 2008 Pg. 247-251
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Bassani August S, Banov Daniel, Lehman Paul A	May/Jun 2008 Pg. 270-273
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A	May/Jun 2008 Pg. 276-278
PreScription: First Estriol, Then What? Allen Loyd V Jr	Jul/Aug 2008 Pg. 284
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Allen Loyd V Jr, Okeke Claudia C	Jul/Aug 2008 Pg. 344-353
Zirconium Oxide Lotion Allen Loyd V Jr	Jul/Aug 2008 Pg. 364
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise	Jul/Aug 2008 Pg. 365-367
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Gupta Vishnu D	Jul/Aug 2008 Pg. 372-374
PostScription: It Is Not Just What You Say…But How You Say It! Reed-Kane Dana	Jul/Aug 2008 Pg. 375
Estriol: Women's Choice vs. A Manufacturer's Greed Goodrum Jennifer	Jul/Aug 2008 Pg. 286-292
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol	Jul/Aug 2008 Pg. 295-304
The Magic of Magnesium Boomsma Diane	Jul/Aug 2008 Pg. 306-309
Progesterone and Traumatic Brain Injury: A Review of Literature Williams LaVonn A, Mead Jay H	Jul/Aug 2008 Pg. 310-315
Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting McElhiney Linda F	Jul/Aug 2008 Pg. 316-320
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane	Jul/Aug 2008 Pg. 321-327
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie	Jul/Aug 2008 Pg. 329-333
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Westrick Salisa C, Felkey Bill G	Jul/Aug 2008 Pg. 334-337
Marketing for Your Community Storey Patricia L	Jul/Aug 2008 Pg. 338-339
Quality-Control Analytical Methods: Homogeneity of Dosing Forms Kupiec Thomas C, Vu Nicole, Branscum David	Jul/Aug 2008 Pg. 340-343
Calculations Stockton Shelly J	Jul/Aug 2008 Pg. 354
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Allen Loyd V Jr	Jul/Aug 2008 Pg. 355
Silicone Cream Allen Loyd V Jr	Jul/Aug 2008 Pg. 356
Sodium Chloride 0.9% Ointment Allen Loyd V Jr	Jul/Aug 2008 Pg. 357
Squalene 0.2% Cream Allen Loyd V Jr	Jul/Aug 2008 Pg. 358
Sucralfate and Hyaluronic Acid Ointment Allen Loyd V Jr	Jul/Aug 2008 Pg. 359
Tretinoin and (-)Alpha-Bisabolol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 360
Tretinoin and Dexpanthenol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 361
Ultrasonic Adhesive Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 362
Vitamin A Suppository Allen Loyd V Jr	Jul/Aug 2008 Pg. 363
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Jul/Aug 2008 Pg. 368-371
PreScription: Compounding Around the World Allen Loyd V Jr	Sep/Oct 2008 Pg. 382
Canine Public Servants: Caring for Drug Detection Dogs Davidson Gigi S	Sep/Oct 2008 Pg. 384-390
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Mixon William, Helms Scott R	Sep/Oct 2008 Pg. 392-397
Veterinary Compounding for Myasthenia Gravis Davidson Gigi S	Sep/Oct 2008 Pg. 398-401
Equine Anesthesia: Triple Drip Davidson Gigi S	Sep/Oct 2008 Pg. 402-404
Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information Neal Amy S, DeVeau Ian, Schnatz Rick G	Sep/Oct 2008 Pg. 405-409
Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship Kirk Loren Madden	Sep/Oct 2008 Pg. 410-413
Calculations Stockton Shelly J	Sep/Oct 2008 Pg. 444-445
Aceclofenac 1.5% Gel-Cream Allen Loyd V Jr	Sep/Oct 2008 Pg. 446
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H	Sep/Oct 2008 Pg. 456-459
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A	Sep/Oct 2008 Pg. 460-462
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Shields David E, Aclan Jennifer, Szatkowski Aaron	Sep/Oct 2008 Pg. 463-466
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie	Sep/Oct 2008 Pg. 414-418
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? Baker Kenneth R	Sep/Oct 2008 Pg. 420-424
Excipient Choices for Special Populations Nagel-Edwards Karen M, Ko James Y	Sep/Oct 2008 Pg. 426-430
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations Cabaleiro Joe	Sep/Oct 2008 Pg. 432-433
Technology for the Patient-Centric Pharmacy Felkey Bill G	Sep/Oct 2008 Pg. 434-437
Acetaminophen 10-mg/mL Rectal Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 447
Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 448
Marketing: Taking Your Show on the Road Storey Patricia L	Sep/Oct 2008 Pg. 438-439
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Allen Loyd V Jr, Okeke Claudia C	Sep/Oct 2008 Pg. 440-443
Dichlorobenzyl Alcohol Tooth Gel Allen Loyd V Jr	Sep/Oct 2008 Pg. 449
Estradiol 0.1% Vaginal Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 450
Flurandrenolide Topical Film Allen Loyd V Jr	Sep/Oct 2008 Pg. 451
Ketoprofen 20% Topical Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 452
Lidocaine Adhesive System Gel Allen Loyd V Jr	Sep/Oct 2008 Pg. 453
Piroxicam 5% and Dexpanthenol 5% Gel Allen Loyd V Jr	Sep/Oct 2008 Pg. 454
Propafenone 1.5-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2008 Pg. 455
PostScription: The International Society of Pharmaceutical Compounding: A Discussion of Its Importance from the Perspective of ISPhC Leadership Marro Diego, Barbosa Carlos Mauricio	Sep/Oct 2008 Pg. 467
Prescription: Is "Globalization" a Good Idea? Allen Loyd V Jr	Nov/Dec 2008 Pg. 474
Arthritis Epidemiology Impacts Pharmacists Vance Dwight A	Nov/Dec 2008 Pg. 476-480
Compounding Challenges for Immunocompromised Patients McElhiney Linda F	Nov/Dec 2008 Pg. 482-487
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Symbols: Historic and Current Uses Bailey Emilee	Nov/Dec 2008 Pg. 505-507
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie	Nov/Dec 2008 Pg. 508-513
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Trissel Lawrence A	Nov/Dec 2008 Pg. 524-528
Calculations Stockton Shelly J	Nov/Dec 2008 Pg. 539
Glycerin, Sterile Allen Loyd V Jr	Nov/Dec 2008 Pg. 542
Indomethacin 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 543
Ketorolac Tromethamine 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 544
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Allen Loyd V Jr	Nov/Dec 2008 Pg. 546
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Paoletti Jim	Nov/Dec 2008 Pg. 488-497
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where Baker Kenneth R	Nov/Dec 2008 Pg. 514-523
Branding: Give Your Small Business a Big Image Storey Patricia L	Nov/Dec 2008 Pg. 537-538
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 540
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 541
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 545
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 547
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 548
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches Allen Loyd V Jr	Nov/Dec 2008 Pg. 549
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties Donnelly Ronald F, Corman Celine	Nov/Dec 2008 Pg. 550-552
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Shields David E, Aclan Jennifer, Szatkowski Aaron	Nov/Dec 2008 Pg. 553-557
PostScription: Supporting Compounding Around the World Allen Loyd V Jr	Nov/Dec 2008 Pg. 565
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr	Nov/Dec 2008 Pg. 530-536
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary	Nov/Dec 2008 Pg. 558-564
Return to Top